Gilead Sciences (LIM:GILD) FCF Yield % : 9.11 (As of Apr. 27, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Gilead Sciences FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Gilead Sciences's Trailing 12-Month Free Cash Flow is $7,421 Mil, and Market Cap is $81,499 Mil. Therefore, Gilead Sciences's FCF Yield % for today is 9.11%.

The historical rank and industry rank for Gilead Sciences's FCF Yield % or its related term are showing as below:

LIM:GILD' s FCF Yield % Range Over the Past 10 Years
Min: 2.06 Med: 9.48 Max: 19.35
Current: 9.11

During the past 13 years, the highest FCF Yield % of Gilead Sciences was 19.35%. The lowest was 2.06%. And the median was 9.48%.

LIM:GILD's FCF Yield % is ranked better than
88.61% of 1080 companies
in the Drug Manufacturers industry
Industry Median: -0.65 vs LIM:GILD: 9.11

Gilead Sciences's FCF Margin % for the quarter that ended in Dec. 2023 was 27.47%.

Gilead Sciences FCF Yield % Historical Data

The historical data trend for Gilead Sciences's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gilead Sciences FCF Yield % Chart

Gilead Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

11.96

8.45

7.85

Gilead Sciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial															9.66	6.62	8.91	6.61	8.27

Competitive Comparison of Gilead Sciences's FCF Yield %

For the Drug Manufacturers - General subindustry, Gilead Sciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gilead Sciences's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gilead Sciences's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Gilead Sciences's FCF Yield % falls into.

Gilead Sciences FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Gilead Sciences's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	7421	/	94487.2132
	=	7.85%

Gilead Sciences's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	1954	*	4	/	94487.2132
	=	8.27%

Gilead Sciences FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Gilead Sciences FCF Yield % Related Terms

Thank you for viewing the detailed overview of Gilead Sciences's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Gilead Sciences (LIM:GILD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gilead Sciences Inc (LIM:GILD) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

GILD:USA GILD:Mexico GILD:Italy GISd:UK 0QYQ:UK GIS:Germany GILD34:Brazil GILD:Austria GILD:Argentina

Address

333 Lakeside Drive, Foster, CA, USA, 94404

Website

https://www.gilead.com

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.